BNP Paribas Financial Markets’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-7,573
| Closed | -$28K | – | 3661 |
|
|
2017
Q4 | $28K | Buy |
7,573
+4,228
| +126% | +$15.6K | ﹤0.01% | 3227 |
|
|
2017
Q3 | $13.7K | Sell |
3,345
-248
| -7% | -$1.01K | ﹤0.01% | 3240 |
|
|
2017
Q2 | $13.3K | Buy |
+3,593
| New | +$13.3K | ﹤0.01% | 3302 |
|
|
2016
Q1 | – | Sell |
-3,187
| Closed | -$42.4K | – | 3385 |
|
|
2015
Q4 | $42.4K | Sell |
3,187
-114
| -3% | -$1.52K | ﹤0.01% | 2922 |
|
|
2015
Q3 | $54.3K | Buy |
3,301
+1,882
| +133% | +$30.9K | ﹤0.01% | 2796 |
|
|
2015
Q2 | $31.8K | Buy |
1,419
+1,048
| +282% | +$23.5K | ﹤0.01% | 2753 |
|
|
2015
Q1 | $3.63K | Buy |
+371
| New | +$3.63K | ﹤0.01% | 3312 |
|
|
2014
Q4 | – | Sell |
-793
| Closed | -$9.13K | – | 3231 |
|
|
2014
Q3 | $9.13K | Buy |
793
+572
| +259% | +$6.59K | ﹤0.01% | 3129 |
|
|
2014
Q2 | $4.3K | Hold |
221
| – | – | ﹤0.01% | 2195 |
|
|
2014
Q1 | $3.8K | Hold |
221
| – | – | ﹤0.01% | 2050 |
|
|
2013
Q4 | $2.34K | Buy |
+221
| New | +$2.34K | ﹤0.01% | 3071 |
|